Back to Blog
A Germany-based pharmaceutical multinational is set to trial IBM blockchain in Canada in a bid to raise the quality of clinical trials. Boehringer Ingelheim (Canada) announced Tuesday that it has partnered with IBM “to improve trust, transparency, patient safety and patient empowerment in clinical trials” using the tech giant’s blockchain platform. The firm said the… The post Pharma Giant Trials IBM Blockchain in Bid to Improve Clinical Trials appeared first on Complete Bitcoin Guide for Beginners. via Tumblr Pharma Giant Trials IBM Blockchain in Bid to Improve Clinical Trials
0 Comments
read more
Leave a Reply. |